About this trial
To investigate the efficacy and safety of the application of PRF combined PRP to the for the treatment of GPN.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age >18 years;
diagnosed with idiopathic GPN according to the third International Classification of Headache Disorders (ICHD) classification;
patients who failed pharmacotherapy or intolerable side effects of medication;
undergoing PRF for GPN;
Disqualifiers
Patients with bilateral GPN;
Abnormalities in blood measurements, liver and kidney function, blood glucose, coagulation, electrocardiography or chest radiography;
Infection at the puncture site;
Previous mental illness;
Trial population
Suitable participants will be screened at the pain management center of each hospital to participate in the study.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Numeric rating scale (NRS) score
Numeric rating scale (NRS) score during resting was used to evaluate pain intensity before and after PRF treatment (0=no pain, 10=intolerable pain)
Secondary outcomes
Barrow Neurological Institute pain scale(BNI score)
BNI score during resting was used to evaluate pain relief
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Beijing Tiantan Hospital
Lead sponsor
China-Japan Friendship Hospital
Collaborator
The Second Hospital of Hebei Medical University
Collaborator